Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04793867 · ClinicalTrials.gov registry record
Regional Phenotyping of CF and Non-CF Bronchiectasis
A clinical trial of Cystic Fibrosis and Non-CF Bronchiectasis, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04793867 is a study of Cystic Fibrosis and Non-CF Bronchiectasis that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 100 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04793867, a study of Cystic Fibrosis and Non-CF Bronchiectasis, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The Investigators propose to study pediatric subjects who are diagnosed with cystic fibrosis (CF) and patients with non-CF bronchiectasis, with the goal of developing markers of CF lung disease severity, progression, and therapy response. The Investigator's central hypothesis is that image-based markers can forecast pathophysiology prior to spirometric changes.
Conditions Studied
Interventions
- DRUG Xenon
Study Locations (1)
Ohio
- Penny New - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-02-08 |
| Est. Completion | 2027-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04793867
The ClinicalTrials.gov registry entry for NCT04793867 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (44% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Xenon is the first listed.
NCT04793867 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04793867 about?
NCT04793867 is a clinical study titled "Regional Phenotyping of CF and Non-CF Bronchiectasis". The Investigators propose to study pediatric subjects who are diagnosed with cystic fibrosis (CF) and patients with non-CF bronchiectasis, with the goal of developing markers of CF lung disease severity, progression, and therapy response. The Investigator's central hypothesis is that image-based mar...
What is the current status of trial NCT04793867?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-02-08. Estimated completion is 2027-03-31.
What conditions does trial NCT04793867 study?
This clinical trial studies the following conditions: Cystic Fibrosis, Non-CF Bronchiectasis.
What interventions are being tested in trial NCT04793867?
The interventions under investigation include: Xenon (DRUG).
Who is sponsoring clinical trial NCT04793867?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04793867 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RECRUITING · Phase 2
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RECRUITING
-
Assessing Tenapanor as a Treatment of CF-related Constipation.
RECRUITING · Phase 3
-
Genetics of Insulin and Incretins in Cystic Fibrosis
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.